Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

49.62
Delayed Data
As of Jul 26
 -0.15 / -0.30%
Today’s Change
31.25
Today|||52-Week Range
58.46
-12.29%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close49.77
Today’s open49.63
Day’s range49.16 - 50.05
Volume1,010,419
Average volume (3 months)1,119,605
Market cap$4.3B
Dividend yield--
Data as of 07/26/2016

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-84.05%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book10.11

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+1.20+4.09%
CTLTCatalent Inc-0.04-0.16%
XONIntrexon Corp+0.23+0.94%
KITEKite Pharma Inc+0.49+0.95%
Data as of 07/26/2016

Financials

Last reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs